ESSA Pharma Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ESSA Pharma Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • ESSA Pharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $197K, a 1156% increase year-over-year.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$68.2K, a 127% decline from 2022.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $253K.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $142M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$68.2K -$321K -127% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-12
2022 $253K -$142M Oct 1, 2021 Sep 30, 2022 10-K 2023-12-12
2021 $142M* +$100M Oct 1, 2020 Sep 30, 2021 10-K 2022-12-13
2020 $41.8M -$8.79M -17.4% Oct 1, 2019 Sep 30, 2020 10-K 2021-11-18
2019 $50.6M Oct 1, 2018 Sep 30, 2019 10-K 2021-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.